NTI 0.00% 7.3¢ neurotech international limited

Ann: Trading Halt, page-70

  1. 6,686 Posts.
    lightbulb Created with Sketch. 1676

    The other question is given Neuren’s drug was recently approved my main question is given Neuren has been granted ODD for the Rett syndrome does this give them 7 year marketing exclusivity or not? The FDA approval for Daybue didn’t mention exclusivity granted for their drug (they got paediatric rare drug PRV) so I am guessing we can also stand to get marketing approval if we fly past phase 3.

    https://data-api.marketindex.com.au/api/v1/announcements/XASX:NEU:2A1436933/pdf/inline/fda-approves-daybue-the-first-treatment-for-rett-syndrome

    https://hotcopper.com.au/data/attachments/6111/6111491-bfe0de1a743e92c3aa1dbea8c841e6ba.jpg
    https://hotcopper.com.au/data/attachments/6111/6111494-bb1113fde8a1d97d822c561eb71f5057.jpg
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.3¢
Change
0.000(0.00%)
Mkt cap ! $74.26M
Open High Low Value Volume
7.4¢ 7.4¢ 7.3¢ $18.40K 250.6K

Buyers (Bids)

No. Vol. Price($)
1 159717 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 125286 4
View Market Depth
Last trade - 14.11pm 05/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.